Search research articles
Contact Us
Filters
Showing results (111-120 of 120) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 120 results.
Innovations in Clinical Neuroscience
|
July 15, 2016
Data Quality Monitoring in Clinical Trials: Has It Been Worth It? An Evaluation and Prediction of the Future by All Stakeholders
, David Daniel, Amir Kalali, et al.
Innovations in Clinical Neuroscience
|
August 12, 2022
SIBAT-A Computerized Assessment Tool for Suicide Ideation and Behavior: Development and Psychometric Properties
Larry Alphs, Dong-Jing Fu, David Williamson, et al.
Archives of General Psychiatry
|
January 7, 2003
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT)
Herbert Y Meltzer, Larry Alphs, Alan I Green, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
October 26, 2017
Considerations for the assessment of suicidal ideation and behavior in older adults with cognitive decline and dementia
Larry Alphs, H Robert Brashear, Phillip Chappell, et al.
Schizophrenia Bulletin Open
|
August 15, 2024
Remote Assessment of Negative Symptoms of Schizophrenia
David G Daniel, Alex S Cohen, Dawn Velligan, et al.
JAMA Psychiatry
|
September 10, 2025
ANK3 as a Novel Genetic Biomarker for Liafensine in Treatment-Resistant Depression: The ENLIGHTEN Randomized Clinical Trial
Gang Wang, Mario Aguado, Matthew A Spear, et al.
Schizophrenia Bulletin
|
August 30, 2008
What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?
Aaron S Kemp, Nina R Schooler, Amir H Kalali, et al.
The American Journal of Psychiatry
|
February 3, 2007
Comments on "Presidential address: advocacy as leadership"
Cathryn Clary, Antony Loebel, Ilise Lombardo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 5, 2024
Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical Trials
Silvia Zaragoza Domingo, Jordi Alonso, Montse Ferrer, et al.
Schizophrenia Research
|
September 14, 2013
Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
Stephen R Marder, Larry Alphs, Ion-George Anghelescu, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 120) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 120 results.
Innovations in Clinical Neuroscience
|
July 15, 2016
Data Quality Monitoring in Clinical Trials: Has It Been Worth It? An Evaluation and Prediction of the Future by All Stakeholders
, David Daniel, Amir Kalali, et al.
Innovations in Clinical Neuroscience
|
August 12, 2022
SIBAT-A Computerized Assessment Tool for Suicide Ideation and Behavior: Development and Psychometric Properties
Larry Alphs, Dong-Jing Fu, David Williamson, et al.
Archives of General Psychiatry
|
January 7, 2003
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT)
Herbert Y Meltzer, Larry Alphs, Alan I Green, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
October 26, 2017
Considerations for the assessment of suicidal ideation and behavior in older adults with cognitive decline and dementia
Larry Alphs, H Robert Brashear, Phillip Chappell, et al.
Schizophrenia Bulletin Open
|
August 15, 2024
Remote Assessment of Negative Symptoms of Schizophrenia
David G Daniel, Alex S Cohen, Dawn Velligan, et al.
JAMA Psychiatry
|
September 10, 2025
ANK3 as a Novel Genetic Biomarker for Liafensine in Treatment-Resistant Depression: The ENLIGHTEN Randomized Clinical Trial
Gang Wang, Mario Aguado, Matthew A Spear, et al.
Schizophrenia Bulletin
|
August 30, 2008
What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?
Aaron S Kemp, Nina R Schooler, Amir H Kalali, et al.
The American Journal of Psychiatry
|
February 3, 2007
Comments on "Presidential address: advocacy as leadership"
Cathryn Clary, Antony Loebel, Ilise Lombardo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 5, 2024
Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical Trials
Silvia Zaragoza Domingo, Jordi Alonso, Montse Ferrer, et al.
Schizophrenia Research
|
September 14, 2013
Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
Stephen R Marder, Larry Alphs, Ion-George Anghelescu, et al.
Page
of 12